Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD

Clinical trial NCT04717635 · COMPLETED

Trial details

NCT number: NCT04717635
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Onset Still's Disease

Start date: 2021-03-30
Primary completion: 2025-04-16
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.